Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurogenic Lower Urinary Tract Dysfunction in Women With Multiple Sclerosis.
4-aminopyridine-loaded topical gel for promoting skin regeneration in burn injuries.
Purkinje cell-specific loss of Neurofascin and Ankyrin G causes disruption of axon initial segments, neurodegeneration, and cerebellar ataxia.
Expanding the Clinical Spectrum of LYRM7-Associated Mitochondrial Complex III Deficiency: Insights from New Cases and Literature Review.
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity.
Whole-body in vivo MPI cytometry reveals injection route-, dose-, cell size-, and disease-dependent differences in organ distribution.
STING-dependent microglial inhibition by irisin ameliorates neuroinflammation in experimental autoimmune encephalomyelitis.
Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis.
Preservation of positive emotion recognition in patients with multiple sclerosis: Artefact related to methodological issues or real feature of the disorder?
From Eight-and-a-Half to Nine: A Case Report Highlighting an Uncommon Brainstem Syndrome.
ABCA1-mediated lipid efflux restrains oxidative stress and neuroinflammation after spinal cord injury.
Bibliometric Analysis of White Matter Disease and Novel Drug Therapy.
Acute Effects of Virtual Reality-Based Optokinetic Stimulation: Comparison of Individuals with Multiple Sclerosis With and Without Central Vestibular Dysfunction.
Low dose intranasal nestorone self-emulsifying drug delivery system promotes neuroprotection in experimental stroke through modulation of glial cells.
Association between cognitive dysfunction and upper extremity performance in multiple sclerosis: a cross-sectional study : Irish journal of medical science.
ALDH2 deficiency exacerbates acrolein-mediated neuropathology in multiple sclerosis.
Disproportionality Analysis and Timing of Drug-Associated Guillain-Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database.
Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis.
Baseline Oculomotor Parameters Are Prospectively Associated with Cognitive Processing Speed at 6-Year Follow-Up in Multiple Sclerosis: An Exploratory Cohort Study.
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis.
Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities.
Ultra-low-field MRI for bedside imaging of severe multiple sclerosis.
Stroke literacy in a sample of Italian adults: an iceberg model revealing domain-specific gaps beyond apparent emergency awareness.
Epstein-Barr virus-associated multiple sclerosis: recent mechanistic advances and clinical therapeutic perspectives.
Local and global patterns support medical imaging as a biomarker of ageing.
Pages
« first
‹ previous
…
1014
1015
1016
1017
1018
1019
1020
1021
1022
…
next ›
last »